Skip to main content

Cramer says the growing popularity of weight loss drugs brings new investing opportunities

CNBC's Jim Cramer on Monday highlighted sectors that may benefit from the increased usage of GLP-1 drugs.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.